Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 7/20 | 0.66 |
| ▸ | TYR | P14679 | 4/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | IDH1 | O75874 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kojic Acid SCHEMBL36895 | 0.79 | TYR (1.00) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL5011817 | 0.79 | TYR (1.00) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL9541984 | 0.79 | TYR (0.81) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL28491069 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL28654757 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL29043760 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL30518398 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL28650749 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL28808848 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 | |
| Kojic Acid SCHEMBL9780977 | 0.78 | TYR (0.96) | DAOTYRKDM4EIDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1495020-A1 | N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003082863-A1 | N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2003-10-09 | — | — | WO | disclosed |